




Instance: composition-en-d6a8f1a1ebaa6583d4e909e9b830debb
InstanceOf: CompositionUvEpi
Title: "Composition for levitra Package Leaflet"
Description:  "Composition for levitra Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpdef564168f4075ea6c8bb0804265caa3)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - levitra"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Levitra is and what it is used for </li>
<li>What you need to know before you take Levitra </li>
<li>How to take Levitra </li>
<li>Possible side effects </li>
<li>How to store Levitra </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What levitra is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What levitra is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Levitra contains vardenafil, a member of a class of medicines called phosphodiesterase type 5 inhibitors. 
They are used for the treatment of erectile dysfunction in adult men, a condition which implies 
difficulties in getting or keeping an erection. </p>
<p>At least one in ten men has trouble getting or keeping an erection at some time. There may be physical or 
psychological causes, or a mixture of both. Whatever the cause is, due to muscle and blood vessel 
changes not enough blood stays in the penis to make it hard and keep it hard. </p>
<p>Levitra will only work when you are sexually stimulated. It reduces the action of the natural chemical in 
your body which makes erections go away. Levitra allows an erection to last long enough for you to 
satisfactorily complete sexual activity. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take levitra"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take levitra"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Levitra 
- If you are allergic to vardenafil or any of the other ingredients of this medicine (listed in section 
6). Signs of an allergic reaction include a rash, itching, swollen face or lips and shortness of 
breath. 
- If you are taking medicines containing nitrates, such as glycerol trinitrate for angina, or nitric 
oxide donors, such as amyl nitrite. Taking these medicines with Levitra could seriously affect 
your blood pressure. 
- If you are taking ritonavir or indinavir, medicines used to treat human immunodeficiency virus 
(HIV) infections. 
- If you are over 75 years of age and are taking ketoconazole or itraconazole, anti-fungal medicines. 
- If you have a severe heart or liver problem. 
- If you are having kidney dialysis. 
- If you have recently had a stroke or heart attack. 
- If you have or have had low blood pressure. 
- If your family has a history of degenerative eye diseases (such as retinitis pigmentosa). 
- If you have ever had a condition involving loss of vision due to damage to the optic nerve from 
insufficient blood supply known as non-arteritic ischemic optic neuropathy (NAION). 
- If you are taking riociguat. This drug is used to treat pulmonary arterial hypertension (i.e. high 
blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (i.e. high 
blood pressure in the lungs secondary to blood clots). PDE5 inhibitors, such as Levitra have been 
shown to increase the hypotensive effects of this medicine. If you are taking riociguat or are 
unsure tell your doctor. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Levitra. </p>
<p>Take special care with Levitra 
- If you have heart trouble. It may be risky for you to have sex. 
- If you suffer from irregular heart beat (cardiac arrhythmia) or inherited heart diseases affecting 
your electrocardiogram. 
- If you have a physical condition affecting the shape of the penis. This includes conditions called 
angulation, Peyronie s disease and cavernosal fibrosis. 
- If you have an illness that can cause erections which won t go away (priapism). These include 
sickle cell disease, multiple myeloma and leukaemia. 
- If you have stomach ulcers (also called gastric or peptic ulcers). 
- If you have a bleeding disorder (such as haemophilia). 
- If you are using any other treatments for erection difficulties, including Levitra orodispersible 
tablets (see section Other medicines and Levitra). 
- If you experience sudden decrease or loss of vision, stop taking Levitra and contact your doctor 
immediately. </p>
<p>Children and adolescents 
Levitra is not intended for use by children or adolescents under 18. Other medicines and Levitra 
Please tell your doctor or pharmacist if you are using, have recently used or might use any other 
medicines, including medicines obtained without a prescription. 
Some medicines may cause problems, especially these:</p>
<ul>
<li>Nitrates, medicines for angina, or nitric oxide donors, such as amyl nitrite. Taking these 
medicines with Levitra could seriously affect your blood pressure. </li>
<li>Medicine for the treatment of arrhythmias, such as quinidine, procainamide, amiodarone or 
sotalol. </li>
<li>Ritonavir or indinavir, medicines for HIV. </li>
<li>Ketoconazole or itraconazole, anti-fungal medicines. </li>
<li>Erythromycin or clarithromycin, macrolide antibiotics. </li>
<li>Alpha-blockers, a type of medicine used to treat high blood pressure and enlargement of the 
prostate (as benign prostatic hyperplasia). </li>
<li>Riociguat. </li>
</ul>
<p>Do not use Levitra film-coated tablets combined with any other treatment for erectile dysfunction, 
including Levitra orodispersible tablets. </p>
<p>Levitra with food, drink and alcohol 
- You can take Levitra with or without food but preferably not after a heavy or high-fat meal as this 
may delay the effect. 
- Don t drink grapefruit juice when you use Levitra. It can interfere with the usual effect of the 
medicine. 
- Alcoholic drink can make erection difficulties worse. </p>
<p>Pregnancy and breast-feeding 
Levitra is not for use by women. </p>
<p>Driving and using machines 
Levitra might make some people feel dizzy or affect their vision. If you feel dizzy, or if your vision is 
affected after taking Levitra don t drive or operate any tools or machines. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take levitra"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take levitra"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if 
you are not sure. The recommended dose is 10 mg. </p>
<p>Take a Levitra tablet about 25 to 60 minutes before sexual activity. With sexual stimulation you may 
achieve an erection anywhere from 25 minutes up to four to five hours after taking Levitra. 
- Swallow one tablet with a glass of water. </p>
<p>Do not take Levitra film-coated tablets with any other forms of Levitra. </p>
<p>Do not take Levitra more than once a day. </p>
<p>Tell your doctor if you think Levitra is too strong or too weak. He or she may suggest a switch to an 
alternative Levitra formulation with a different dose, depending on how well it works for you. </p>
<p>If you take more Levitra than you should 
Men who take too much Levitra may experience more side effects or may get severe back pain. If you 
take more Levitra than you should, tell your doctor. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the 
effects are mild or moderate.  </p>
<p>Partial, sudden, temporary or permanent decrease or loss of vision in one or both eyes has been 
experienced by patients. Stop taking Levitra and contact your doctor immediately. 
Sudden decrease or loss of hearing has been reported. </p>
<p>Cases of sudden death, fast or altered heart beat, heart attack, chest pain, and trouble in cerebral 
circulation (including temporarily decreased blood flow to parts of the brain and bleeding in the brain) 
have been reported in men taking vardenafil. Most of the men who experienced these side effects had 
heart problems before taking this medicine. It is not possible to determine whether these events were 
directly related to vardenafil. </p>
<p>The chance of having a side effect is described by the following categories: </p>
<p>Very common: 
may affect more than 1 in 10 users 
- Headache </p>
<p>Common: 
may affect up to 1 in 10 users 
- Dizziness 
- Flushing 
- Blocked or runny nose 
- Indigestion </p>
<p>Uncommon: 
may affect up to 1 in 100 users 
- Swelling of skin and mucous tissue including swollen face, lips or throat 
- Sleep disorder 
- Numbness and impaired perception of touch<br />
- Sleepiness 
- Effects on vision, redness of the eye, effects on colour vision, eye pain and discomfort, light 
sensitivity 
- Ringing in the ears, vertigo<br />
- Fast heart beat or pounding heart<br />
- Breathlessness 
- Stuffy nose 
- Acid reflux, gastritis, abdominal pain, diarrhoea, vomiting, feeling sick (nausea), dry mouth 
- Raised levels of liver enzymes in your blood 
- Rash, reddened skin 
- Back or muscle pain, increase in blood of a muscle enzyme (creatine phosphokinase), muscle 
stiffness 
- Prolonged erections 
- Malaise  </p>
<p>Rare: 
may affect up to 1 in 1,000 users 
- Inflammation of the eyes (conjunctivitis) 
- Allergic reaction<br />
- Anxiety 
- Fainting<br />
- Amnesia<br />
- Seizure 
- Increased pressure in the eye (glaucoma), lacrimation increased 
- Effects on the heart (such as heart attack, altered heart beat or angina) 
- High or low blood pressure<br />
- Nose bleed 
- Effect on results of blood tests to check liver function 
- Sensitivity of the skin to sun light 
- Painful erections 
- Chest pain 
- Temporarily decreased blood flow to parts of the brain </p>
<p>Very rare or not known: 
may affect less than 1 in 10,000 users or frequency cannot be estimated from the available data 
- Blood in the urine (Haematuria) 
- Penile bleeding (Penile Haemorrhage) 
- Presence of blood in the semen (Haematospermia) 
- Sudden death 
- Bleeding in the brain </p>
<p>Reporting of side effects<br />
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this 
leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. 
By reporting side effects, you can help provide more information on the safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store levitra"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store levitra"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton after  EXP . The expiry date 
refers to the last day of that month. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Levitra contains 
- The active substance is vardenafil. Each tablet contains 5 mg of vardenafil (as hydrochloride). 
- The other ingredients of the tablets are: 
Tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, colloidal anhydrous 
silica. 
Film coat: macrogol 400, hypromellose, titanium dioxide (E171), ferric oxide yellow (E172), 
ferric oxide red (E172). </p>
<p>What Levitra looks like and contents of the pack 
Levitra 5 mg film-coated tablets are orange with the BAYER cross on one side and the strength (5) on 
the other side. The tablets are provided in blister packs containing 2, 4, 8, 12 or 20 tablets. Not all pack 
sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer </p>
<p>Marketing Authorisation Holder<br />
Bayer AG 
51368 Leverkusen 
Germany </p>
<p>Manufacturer 
Bayer AG 
Kaiser-Wilhelm-Allee 
51368 Leverkusen 
Germany </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder. </p>
<p>Belgi /Belgique/Belgien 
Bayer SA-NV 
T l/Tel: +32-(0)2-535 63 Lietuva 
UAB Bayer 
Tel: +370 523 36   </p>
<p>T .: +359-(0)2-424 72 Luxembourg/Luxemburg 
Bayer SA-NV 
T l/Tel: +32-(0)2-535 63  esk  republika 
Bayer s.r.o. 
Tel: +420 266 101 Magyarorsz g 
Bayer Hung ria KFT 
Tel.: +36 14 87-4Danmark 
Bayer A/S 
Tlf: +45 45 23 50 Malta 
Alfred Gera and Sons Ltd. 
Tel: +35 621 44 62 Deutschland 
Jenapharm GmbH &amp; Co. KG 
Tel: +49 (0)3641-87 97 Nederland 
Bayer B.V. 
Tel: +31-(0)23 799 1Eesti 
Bayer O<br />
Tel: +372 655 85 Norge 
Bayer AS 
Tlf: +47-23 13 05 <br />
Bayer   <br />
 : +30 210 61 87  sterreich 
Bayer Austria Ges. m. b. H. 
Tel: +43-(0)1-711 46-0 
Espa a 
Bayer Hispania S.L. 
Tel: +34-93-495 65 Polska 
Bayer Sp. z o.o. 
Tel.: +48 22 572 35 France 
Bayer HealthCare 
T l (N  vert) : +33-(0)800 87 54 Portugal 
Bayer Portugal, Lda. 
Tel: +351 21 416 42 Hrvatska 
Bayer d.o.o. 
Tel: + 385-(0)1-6599 Rom nia 
SC Bayer SRL. 
Tel: +40-21-529 59 Ireland 
Bayer Limited 
Tel: +353 1 216 3Slovenija 
Bayer d. o. o. 
Tel: +386 (0)1 58 14  sland 
Icepharma hf. 
S mi: +354-540 8Slovensk  republika 
Bayer, spol. s r.o. 
Tel: +421 2-59 21 31 Italia 
Bayer S.p.A. 
Tel: +39 02 397 Suomi/Finland 
Bayer Oy 
Puh/Tel: +358-20 785 <br />
NOVAGEM Limited 
 : +357 22 48 38 Sverige 
Bayer AB 
Tel: +46 (0)8 580 223 Latvija 
SIA Bayer 
Tel: +371 67 845 United Kingdom (Northern Ireland) 
Bayer AG<br />
Tel: +44-(0)118 206 3This leaflet was last revised in  </p>
<p>Other sources of information 
Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-d6a8f1a1ebaa6583d4e909e9b830debb
InstanceOf: CompositionUvEpi
Title: "Composition for levitra Package Leaflet"
Description:  "Composition for levitra Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpdef564168f4075ea6c8bb0804265caa3)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - levitra"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen: 
1. Virkning og anvendelse 
2. Det skal De vide, før De begynder at tage Levitra 
3. Sådan skal De tage Levitra 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What levitra is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What levitra is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Levitra indeholder vardenafil og tilhører en gruppe lægemidler, der kaldes fosfodiesterase type 5-
hæmmere. De anvendes til behandling af voksne mænd med manglende evne til at få eller 
vedligeholde rejsning af penis (erektil dysfunktion). </p>
<p>Mindst 1 ud af 10 mænd har problemer med at opnå eller vedligeholde en erektion over et givent 
tidsrum. Dette kan skyldes fysiske eller psykologiske årsager, eller mest sandsynligt en kombination af 
begge dele. Uanset årsagen er effekten den samme: Muskel- og blodkarsændringer gør, at der ikke er 
tilstrækkeligt blod i penis til at opnå og bevare stivhed. </p>
<p>Levitra fungerer kun i forbindelse med seksuel stimulation. Det nedsætter funktionen af det naturlige 
stof i kroppen, der fjerner en erektion. Levitra lader en erektion vare længe nok til, at De på 
tilfredsstillende måde kan gennemføre en seksuel aktivitet. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take levitra"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take levitra"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Levitra 
- Hvis De er allergisk over for vardenafil eller et af de øvrige indholdsstoffer i Levitra (angivet i 
punkt 6). Tegn på en allergisk reaktion omfatter hududslæt, kløe, opsvulmet ansigt, opsvulmede 
læber og åndenød. 
- Hvis De tager medicin, som indeholder nitrater, som nitroglycerin for angina, eller 
nitrogenoxid-donorer som amylnitrit. Indtagelse af denne medicin sammen med Levitra kan 
have en alvorlig påvirkning på Deres blodtryk. 
- Hvis De tager ritonavir eller indinavir, medicin mod human immundefekt virusinfektion (HIV). 
- Hvis De er over 75 år og tager ketoconazol eller itraconazol, medicin mod svampeinfektioner. 
- Hvis De har et alvorligt hjerte- eller leverproblem. 
- Hvis De modtager dialysebehandling. 
- Hvis De for nylig har haft et slagtilfælde eller hjertetilfælde. 
- Hvis De har eller har haft lavt blodtryk. 
- Hvis der i Deres familie har været tilfælde af degenerative øjensygdomme (som f.eks. retinitis 
pigmentosa). 
- Hvis De på noget tidspunkt tidligere har haft tab af synet på grund af beskadigelse af 
synsnerven i forbindelse med utilstrækkelig forsyning af blod til synsnerven, også kendt som 
non-arteritis anterior iskæmisk opticusneuropati (NAION). 
- Hvis De tager riociguat. Dette lægemiddel bruges til at behandle pulmonal arteriel hypertension 
(dvs. højt blodtryk i lungerne) og kronisk tromboembolisk pulmonal hypertension (dvs. højt 
blodtryk i lungerne som følge af blodpropper). PDE5-hæmmere, så som Levitra, har vist sig at 
øge den blodtrykssænkende virkning af denne medicin. Tal med Deres læge, hvis De tager 
riociguat eller er usikker. </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før De tager Levitra. </p>
<p>Vær ekstra forsigtig med at tage Levitra 
- Hvis De har problemer med hjertet. Det kan være risikabelt for Dem at have sex. 
- Hvis De lider af hjerterytmeforstyrrelser eller en medfødt hjertesygdom, der påvirker Deres 
elektrokardiogram. 
- Hvis De har en fysisk tilstand, som påvirker formen af penis. Dette omfatter tilstande kaldet 
krummerik, Peyronies plaque og cavernosa fibrose. 
- Hvis De har en sygdom der kan medføre erektioner, som ikke forsvinder (priapisme). Disse 
omfatter seglcelleanæmi, multipel myeloma og leukæmi. 
- Hvis De har mavesår. 
- Hvis De har en blødningsforstyrrelse (som f.eks. hæmofili). 
- Hvis De bruger andre lægemidler for erektionsproblemer, herunder Levitra smeltetabletter (se 
afsnittet "Brug af anden medicin sammen med Levitra"). 
- Hvis De oplever pludselige nedsættelser af synet eller tab af synet, skal De stoppe med at tage 
Levitra og straks søge læge. </p>
<p>Børn og unge 
Levitra er ikke beregnet til børn og unge under 18 år.  </p>
<p>Brug af anden medicin sammen med Levitra 
Fortæl altid lægen eller apotekspersonalet, hvis De bruger anden medicin, for nylig har brugt anden 
medicin eller planlægger at bruge anden medicin. Dette gælder også medicin, som ikke er købt på 
recept, f.eks. naturlægemidler og vitaminer og mineraler. 
Visse typer medicin kan give problemer, især disse:</p>
<ul>
<li>Nitrater, medicin for angina, eller nitrogen-oxid-donorer, som amylnitrit. Indtagelse af disse typer 
medicin sammen med Levitra kan have en alvorlig påvirkning på Deres blodtryk. </li>
<li>Medicin til behandling af hjerterytmeforstyrrelser, som for eksempel quinidin, procainamid, 
amiodaron eller sotalol. </li>
<li>Ritonavir eller indinavir, medicin for HIV. </li>
<li>Ketoconazol eller itraconazol, anti-svampemidler. </li>
<li>Erythromycin eller clarithromycin, antibiotika. </li>
<li>Alfa-blokkere, medicin til behandling af forhøjet blodtryk og godartet forstørret blærehalskirtel. </li>
<li>Riociguat. </li>
</ul>
<p>Tag ikke Levitra filmovertrukne tabletter sammen med anden behandling for erektil dysfunktion, 
herunder Levitra smeltetabletter. </p>
<p>Brug af Levitra sammen med mad, drikke og alkohol 
- De kan tage Levitra uafhængigt af måltider, men helst ikke efter et massivt måltid eller et meget 
fedtholdigt måltid, da det kan forsinke virkningen. 
- Drik ikke grapefrugtjuice, når De bruger Levitra. Det kan påvirke effekten af medicinen. 
- Alkoholiske drikke kan forværre erektionsproblemer. </p>
<p>Graviditet og amning 
Levitra er ikke beregnet til brug hos kvinder. </p>
<p>Trafik- og arbejdssikkerhed 
Levitra kan medføre svimmelhed eller synspåvirkning hos nogle. Hvis De føler Dem svimmel eller 
Deres syn er påvirket efter at have taget Levitra, bør De ikke køre bil eller betjene maskiner. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take levitra"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take levitra"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid dette lægemiddel nøjagtigt efter lægens anvisning. Er De i tvivl, så spørg lægen eller på 
apoteket. Den anbefalede dosis er 10 mg. </p>
<p>Tag en Levitra-tablet cirka 25 til 60 minutter før seksuel aktivitet. I forbindelse med seksuel 
stimulation kan De opnå en erektion i tidsrummet fra 25 minutter op til 4-5 timer efter at have taget 
Levitra. 
- En tablet synkes med et glas vand. </p>
<p>Tag ikke Levitra filmovertrukne tabletter sammen med andre former for Levitra. </p>
<p>De må ikke tage Levitra mere end én gang i løbet af døgnet. </p>
<p>Tal med Deres læge, hvis De mener, at Levitra er for kraftige eller for svage. Lægen kan da foreslå, at 
De skifter til en anden formulering af Levitra med en anden dosis, afhængigt af hvordan virkningen er 
på Dem. </p>
<p>Hvis De har taget for meget Levitra 
Mænd, som tager for meget Levitra, kan opleve flere bivirkninger eller få alvorlige rygsmerter. Fortæl 
lægen, hvis De har taget for meget Levitra. </p>
<p>Spørg lægen eller på apoteket, hvis der er noget, De er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemideler give bivirkninger, men ikke alle får bivirkninger. 
De fleste af bivirkningerne er som regel milde eller moderate. </p>
<p>Nogle patienter har oplevet delvist, pludseligt, midlertidigt eller permanent nedsat syn eller synstab på 
det ene eller begge øjne. Stop med at tage Levitra og kontakt øjeblikkeligt Deres læge.<br />
Der er rapporteret pludseligt nedsat hørelse eller høretab.  </p>
<p>Tilfælde af pludselig død, hurtig eller ændret hjerteslag, hjerteanfald, brystsmerter og problemer i 
cerebral cirkulation (inklusive midlertidigt nedsat blodforsyning til dele af hjernen og blødning i 
hjernen), har været rapporteret hos mænd, der tager vardenafil. De fleste af de mænd, som oplevede 
disse bivirkninger, havde hjerteproblemer, før de tog denne medicin. Det er ikke muligt at afgøre, om 
disse hændelser var direkte relateret til vardenafil. </p>
<p>Risikoen for at få en bivirkning er beskrevet med følgende hyppigheder: </p>
<p>Meget almindelige bivirkninger:<br />
forekommer hos flere end 1 ud af 10 behandlede 
- Hovedpine </p>
<p>Almindelige bivirkninger:<br />
forekommer hos op til 1 ud af 10 behandlede 
- Svimmelhed 
- Ansigtsrødme 
- Stoppet eller rindende næse 
- Fordøjelsesbesvær </p>
<p>Ikke almindelige bivirkninger:<br />
forekommer hos op til 1 ud af 100 behandlede 
-  Hævelser i hud og slimhinder, herunder hævelse i ansigt, læber eller hals<br />
-  Søvnforstyrrelser<br />
-  Følelsesløshed og nedsat fornemmelse af berøring<br />
-  Søvnighed 
-  Påvirkning af synet, røde øjne, ændret farvesyn, øjensmerter og -ubehag, lysfølsomhed<br />
-  Ringen for ørerne, svimmelhed 
-  Hurtig puls eller hjertebanken 
-  Åndenød<br />
-  Stoppet næse 
-  Sure opstød, mavekatar, mavesmerter, diarré, opkastning, kvalme, tør mund<br />
-  Forhøjede niveauer af leverenzymer i blodet<br />
-  Udslæt, hudrødme 
-  Ryg- og muskelsmerter, øget muskelenzym i blodet (kreatinfosfokinase), muskelstivhed<br />
-  Vedvarende erektion 
-  Ubehag </p>
<p>Sjældne bivirkninger:<br />
forekommer hos op til 1 ud af 1.000 behandlede 
- Øjenbetændelse (conjunktivitis) 
- Allergisk reaktion 
- Angst 
- Besvimelse 
- Hukommelsestab 
- Kramper 
- Øget tryk i øjet (glaukom), øget tåreflåd 
- Påvirkning af hjertet (f.eks. hjerteanfald, ændret hjerterytme eller hjertekramper (angina)) 
-  Højt eller lavt blodtryk 
-  Næseblod 
-  Indvirkning på resultaterne af blodprøver for leverfunktion 
-  Øget hudfølsomhed over for sollys 
- Smertefulde erektioner 
- Smerter i brystet 
- Midlertidigt nedsat blodforsyning til dele af hjernen </p>
<p>Meget sjældne eller ikke kendte bivirkninger: 
forekommer hos færre end 1 ud af 10.000 behandlede 
- Blod i urinen (hæmaturi) 
- Blødning fra penis 
- Blod i sæden<br />
- Pludselig død 
- Blødning i hjernen </p>
<p>Indberetning af bivirkninger 
Hvis De oplever bivirkninger, bør De tale med Deres læge. Dette gælder også mulige  bivirkninger, 
som ikke er medtaget i denne indlægsseddel. De eller Deres pårørende kan også indberette 
bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i Appendiks 
V. Ved at indrapportere bivirkninger kan De hjælpe med at fremskaffe mere information om 
sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store levitra"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store levitra"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar dette lægemiddel utilgængeligt for børn. </p>
<p>Brug ikke dette lægemiddel efter den udløbsdato, der står på æsken efter "EXP". Udløbsdatoen er den 
sidste dag i den nævnte måned. </p>
<p>Spørg apotekspersonalet, hvordan De skal bortskaffe medicinrester. Af hensyn til miljøet må De ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Levitra indeholder:</p>
<ul>
<li>Aktivt stof: vardenafil. Hver tablet indeholder 5 mg vardenafil (som hydrochlorid). </li>
<li>Øvrige indholdsstoffer: 
Tabletkernen: Crospovidon, magnesiumstearat, mikrokrystallinsk cellulose, kolloid vandfri 
silica. 
Filmovertræk: Macrogol 400, hypromellose, titandioxid (E 171), gul jernoxid (E 172), rød 
jernoxid (E 172). </li>
</ul>
<p>Udseende og pakningsstørrelser 
Levitra 5 mg filmovertrukne tabletter er orange med BAYER-korset på den ene side og styrken (5) på 
den anden side. Tabletterne findes i blisterpakninger, som indeholder 2, 4, 8, 12, eller 20 tabletter. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller </p>
<p>Indehaver af markedsføringstilladelsen 
Bayer AG 
51368 Leverkusen 
Tyskland </p>
<p>Fremstiller 
Bayer AG 
Kaiser-Wilhelm-Allee 
51368 Leverkusen 
Tyskland </p>
<p>Hvis De ønsker yderligere oplysninger om dette lægemiddel, skal De henvende Dem til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
Bayer SA-NV 
Tél/Tel: +32-(0)2-535 63 Lietuva 
UAB Bayer 
Tel: +370 523 36 България 
Байер България ЕООД 
Tел.: +359-(0)2-424 72 80<br />
Luxembourg/Luxemburg 
Bayer SA-NV 
Tél/Tel: +32-(0)2-535 63 Česká republika 
Bayer s.r.o. 
Tel: +420 266 101 Magyarország 
Bayer Hungária KFT 
Tel.: +36 14 87-4Danmark 
Bayer A/S 
Tlf: +45 45 23 50 Malta 
Alfred Gera and Sons Ltd. 
Tel: +35 621 44 62 Deutschland 
Jenapharm GmbH &amp; Co. KG 
Tel: +49 (0)3641-87 97 Nederland 
Bayer B.V. 
Tel: +31-(0)23 799 1Eesti 
Bayer OÜ 
Tel: +372 655 85 Norge 
Bayer AS 
Tlf: +47-23 13 05 Ελλάδα 
Bayer Ελλάς ΑΒΕΕ 
Τηλ: +30 210 61 87 Österreich 
Bayer Austria Ges. m. b. H. 
Tel: +43-(0)1-711 46-0 
España 
Bayer Hispania S.L. 
Tel: +34-93-495 65 Polska 
Bayer Sp. z o.o. 
Tel.: +48 22 572 35 France 
Bayer HealthCare 
Tél (N° vert) : +33-(0)800 87 54 Portugal 
Bayer Portugal, Lda. 
Tel: +351 21 416 42 Hrvatska 
Bayer d.o.o. 
Tel: + 385-(0)1-6599 România 
SC Bayer SRL. 
Tel: +40-21-529 59 Ireland 
Bayer Limited 
Tel: +353 1 216 3Slovenija 
Bayer d. o. o. 
Tel: +386 (0)1 58 14 Ísland 
Icepharma hf. 
Sími: +354-540 8Slovenská republika 
Bayer, spol. s r.o. 
Tel: +421 2-59 21 31 Italia 
Bayer S.p.A. 
Tel: +39 02 397 Suomi/Finland 
Bayer Oy 
Puh/Tel: +358-20 785 Κύπρος 
NOVAGEM Limited 
Τηλ: +357 22 48 38 Sverige 
Bayer AB 
Tel: +46 (0)8 580 223 Latvija 
SIA Bayer 
Tel: +371 67 845 United Kingdom (Northern Ireland) 
Bayer AG<br />
Tel: +44-(0)118 206 3 
Denne indlægsseddel blev senest ændret  </p>
<p>Andre informationskilder<br />
De kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu. 
Indlægsseddel: Information til brugeren </p>
<p>Levitra 10 mg filmovertrukne tabletter 
vardenafil </p>
<p>Læs denne indlægsseddel grundigt, inden De begynder at tage dette lægemiddel, da den 
indeholder vigtige oplysninger. 
- Gem indlægssedlen. De kan få brug for at læse den igen. 
- Spørg lægen eller apotekspersonalet, hvis der er mere, De vil vide. 
- Lægen har ordineret dette lægemiddel til Dem personligt. Lad derfor være med at give det til 
andre. Det kan være skadeligt for andre, selvom de har de samme symptomer, som De har. 
- Kontakt lægen eller apotekspersonalet, hvis De får bivirkninger, herunder bivirkninger, som 
ikke er nævnt i denne indlægsseddel. Se punkt 4. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-d6a8f1a1ebaa6583d4e909e9b830debb
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for levitra Package Leaflet for language en"
Description: "ePI document Bundle for levitra Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-d6a8f1a1ebaa6583d4e909e9b830debb"
* entry[0].resource = composition-en-d6a8f1a1ebaa6583d4e909e9b830debb

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpd6a8f1a1ebaa6583d4e909e9b830debb"
* entry[=].resource = mpd6a8f1a1ebaa6583d4e909e9b830debb
                            
                    
Instance: bundlepackageleaflet-da-d6a8f1a1ebaa6583d4e909e9b830debb
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for levitra Package Leaflet for language da"
Description: "ePI document Bundle for levitra Package Leaflet for language da"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-d6a8f1a1ebaa6583d4e909e9b830debb"
* entry[0].resource = composition-da-d6a8f1a1ebaa6583d4e909e9b830debb

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpd6a8f1a1ebaa6583d4e909e9b830debb"
* entry[=].resource = mpd6a8f1a1ebaa6583d4e909e9b830debb
                            
                    



Instance: mpd6a8f1a1ebaa6583d4e909e9b830debb
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product levitra"
Description: "levitra"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/03/248/001-004, 021"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* indication = "Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or"


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "levitra"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#DK "DK"
    * jurisdiction = urn:iso:std:iso:3166#DK "DK"
    * language = urn:ietf:bcp:47#en  "en"




RuleSet: d6a8f1a1ebaa6583d4e909e9b830debbListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "levitra"

* status = #current
* mode = #working

* title = "List of all ePIs associated with levitra"

* subject = Reference(mpdef564168f4075ea6c8bb0804265caa3)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#levitra "levitra"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-d6a8f1a1ebaa6583d4e909e9b830debb) // levitra en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-d6a8f1a1ebaa6583d4e909e9b830debb) // levitra da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-d6a8f1a1ebaa6583d4e909e9b830debb
InstanceOf: List

* insert d6a8f1a1ebaa6583d4e909e9b830debbListRuleset
    